
Active Biotech
ACTI | ST
Overview
Corporate Details
- ISIN(s):
- SE0001137985 (+2 more)
- LEI:
- 549300OJ44CLMRU8YE43
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Active Biotech is a biotechnology company that develops pharmaceutical products for medical areas with significant unmet needs, focusing on cancer and inflammatory diseases where the immune system plays a key role. The company leverages its extensive knowledge and portfolio of compounds to advance a pipeline that includes both small, orally active immunomodulatory molecules and antibody-based immunotherapies. Its key development programs target hematological cancers (tasquinimod), inflammatory eye disorders such as uveitis (laquinimod), and solid tumors (naptumomab), the latter in partnership with NeoTX.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Active Biotech.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-21 08:30 |
Interim Report
|
Swedish | 497.6 KB | |
2025-08-21 08:30 |
Interim Report
|
English | 492.9 KB | |
2025-06-17 15:15 |
Major Shareholding Notification
|
Swedish | 10.7 KB | |
2025-05-28 18:30 |
Post-Annual General Meeting Information
Annual General Meeting of Active Biotech AB
|
English | 76.1 KB | |
2025-05-28 18:30 |
Post-Annual General Meeting Information
Årsstämma i Active Biotech AB
|
Swedish | 74.1 KB | |
2025-05-08 08:30 |
Quarterly Report
|
Swedish | 406.4 KB | |
2025-05-08 08:30 |
Quarterly Report
|
English | 400.9 KB | |
2025-05-05 09:00 |
Regulatory News Service
Active Biotech rapporterar positiva top line-resultat från LION-studien om okul…
|
Swedish | 104.6 KB | |
2025-05-05 09:00 |
Regulatory News Service
Active Biotech reports positive top-line results from the LION study on ocular …
|
English | 104.9 KB | |
2025-04-28 11:00 |
Pre-Annual General Meeting Information
NOTICE OF ANNUAL GENERAL MEETING
|
English | 98.7 KB | |
2025-04-28 11:00 |
Pre-Annual General Meeting Information
KALLELSE TILL ÅRSSTÄMMA
|
Swedish | 99.3 KB | |
2025-02-13 08:30 |
Annual Report
|
Swedish | 511.4 KB | |
2025-02-13 08:30 |
Annual Report
|
English | 506.2 KB | |
2025-01-31 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Active Biotech
|
English | 86.2 KB | |
2025-01-31 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Active Biotech
|
Swedish | 86.1 KB |
Automate Your Workflow. Get a real-time feed of all Active Biotech filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Active Biotech via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2025-01-10 | Peter Thelin | Other | Other | 164,638,960 | 8,231,948.00 SEK |
2024-11-15 | Hans Kolam | Other | Other | 19,800 | 990.00 SEK |
2022-09-05 | Aleksandar Danilovski | Other | Buy | 26,672 | 26,672.00 SEK |
2022-04-22 | Helen Tuvesson Andersson | Other | Buy | 2,665 | 3,102.86 SEK |
2022-04-21 | Helen Tuvesson Andersson | Other | Buy | 37,335 | 41,767.60 SEK |
2021-06-17 | Aleksandar Danilovski | Other | Buy | 40,000 | 60,000.00 SEK |
2021-06-01 | Michael Shalmi | Other | Buy | 175,000 | 259,437.50 SEK |
2021-04-27 | Helen Tuvesson Andersson | Other | Buy | 10,411 | 16,657.60 SEK |
2021-04-27 | Helena Eriksson | Other | Buy | 10,000 | 14,460.00 SEK |
2021-04-27 | Helen Tuvesson Andersson | Other | Buy | 1,041 | 1,665.60 SEK |